Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic polyclonal immunoblastic proliferations.

L C Peterson1, B Kueck, D C Arthur

  • 1Department of Laboratory Medicine and Pathology, Hennepin County Medical Center, Minneapolis, MN 55415.

Cancer
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimally invasive fixation of a lateral tibial plateau fracture in a dog.

The Journal of small animal practice·2020
Same author

Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.

Allergy·2016
Same author

Deglacial pulses of deep-ocean silicate into the subtropical North Atlantic Ocean.

Nature·2013
Same author

ICSH guidelines for the standardization of bone marrow specimens and reports.

International journal of laboratory hematology·2008
Same author

Plasma cell satellitism in plasma cell myeloma.

Journal of clinical pathology·2006
Same author

Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2004
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

This study details four cases of systemic immunoblastic proliferation, showing rapid regression with chemotherapy and steroids. While immunohistochemistry suggests a reactive process, cytogenetic findings hint at a potential neoplastic clone.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Systemic immunoblastic proliferation presents a diagnostic challenge.
  • Understanding the nature of this proliferation is crucial for patient management.

Observation:

  • Four patients presented with florid, systemic immunoblastic proliferation.
  • Blood and bone marrow showed significant leukocytosis with immunoblasts and plasma cells.
  • Lymph node biopsies revealed effaced architecture due to immunoblast and plasma cell infiltration.

Findings:

  • Immunohistochemistry indicated a polyclonal, reactive proliferative process.
  • Cytogenetic studies identified a pseudodiploid abnormal clone with a 14q32 translocation in two patients.
  • Three patients with immune disorders showed rapid regression following treatment with steroids and chemotherapy.

Related Experiment Videos

Implications:

  • The findings suggest a complex biology, potentially representing a reactive condition or an early neoplastic process.
  • Successful treatment outcomes highlight the efficacy of combined immunomodulatory and chemotherapeutic approaches.
  • Further research is needed to elucidate the exact pathogenesis and long-term prognosis of this condition.